NGL Fine-Chem Limited carries a market capitalization of 19.96B, placing it among publicly traded companies globally. Its enterprise value stands at 13.33B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 19.96B |
| Enterprise Value | 13.33B |
NGL Fine-Chem Limited currently has 6.18M shares outstanding.
| Shares Outstanding | 6.18M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
NGL Fine-Chem Limited trades at a trailing price-to-earnings ratio of 26.45. The price-to-sales ratio is 2.54, and the price-to-book ratio stands at 411.39.
| PE Ratio | 26.45 |
| PS Ratio | 2.54 |
| PB Ratio | 411.39 |
| P/TBV Ratio | 3.86 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, NGL Fine-Chem Limited trades at an EV/EBITDA multiple of 25.51 and an EV/FCF ratio of 393.19. The EV/Sales ratio of 2.66 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 25.51 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.66 |
| EV / EBITDA | 25.51 |
| EV / EBIT | 25.51 |
| EV / FCF | 393.19 |
NGL Fine-Chem Limited maintains a current ratio of 1.84, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 32.96, indicating elevated leverage, while an interest coverage ratio of 11.70 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.84 |
| Quick Ratio | 0.31 |
| Debt / Equity | 32.96 |
| Debt / EBITDA | 2.08 |
| Interest Coverage | 11.70 |
NGL Fine-Chem Limited posts a return on equity of 33.91 and a return on invested capital of 9.94.
| Return on Equity (ROE) | 33.91 |
| Return on Assets (ROA) | 9.82 |
| Return on Invested Capital (ROIC) | 9.94 |
| Return on Capital Employed (ROCE) | 21.94 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.94 |
Over the trailing twelve months, NGL Fine-Chem Limited has paid 152.41M in income taxes, reflecting an effective tax rate of 24.08.
| Income Tax | 152.41M |
| Effective Tax Rate | 24.08 |
NGL Fine-Chem Limited's stock has gained approximately 162.68293% over the past 52 weeks. The 50-day moving average sits at 2,681.50, while the 200-day moving average is 1,974.57.
| Beta (5Y) | N/A |
| 52-Week Price Change | 162.68293% |
| 50-Day Moving Average | 2,681.50 |
| 200-Day Moving Average | 1,974.57 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, NGL Fine-Chem Limited generated 5.01B in revenue and converted that into 480.42M in net income, yielding earnings per share of 77.77. EBITDA reached 522.73M, while operating income came in at 522.73M.
| Revenue | 5.01B |
| Gross Profit | 2.62B |
| Operating Income | 522.73M |
| Pretax Income | 632.83M |
| Net Income | 480.42M |
| EBITDA | 522.73M |
| EBIT | 522.73M |
| Earnings Per Share (EPS) | 77.77 |
NGL Fine-Chem Limited holds 460.23M in cash and equivalents against 1.09B in total debt, resulting in a net debt position of 1.06B. Total book value stands at 30.89M, with working capital of 1.26B providing operational flexibility.
| Cash & Cash Equivalents | 460.23M |
| Total Debt | 1.09B |
| Net Debt | 1.06B |
| Equity (Book Value) | 30.89M |
| Book Value Per Share | 5.00 |
| Working Capital | 1.26B |
NGL Fine-Chem Limited operates with a gross margin of 52.20, reflecting its pricing power and cost economics. The operating margin of 10.43 and net profit margin of 9.59 provide insight into operational efficiency.
| Gross Margin | 52.20 |
| Operating Margin | 10.43 |
| Pretax Margin | 12.63 |
| Profit Margin | 9.59 |
| EBITDA Margin | 10.43 |
NGL Fine-Chem Limited posts an Altman Z-Score of 5.04, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.04 |